Vice President for Research at UT Health Science Center at San Antonio
VP of Research & Policy, Ewing Marion Kauffman Foundation
Vice President for Corporate Engagement, Rose-Hulman Institute of Technology
Managing Partner at Pappas Ventures
The San Diego Venture Group has invited Domain Associates partner Eckard Webber and Regulas Therapeutics CEO Kleanthis Xanthopoulos to discuss how life sciences financing has changed in recent years. Inquiring minds want to know: How does royalty-based financing work at an early stage company? Should companies submit their IPO filings confidentially under the new provisions of the JOBS Act? Should companies consider an option deal as an alternative to another private round? More information and online registration is here.